Pharmacokinetics and safety of erlotinib and its metabolite OSI-420 in infants and children with primary brain tumors

被引：0
|
作者：
Samuel J. Reddick
Olivia Campagne
Jie Huang
Arzu Onar-Thomas
Alberto Broniscer
Amar Gajjar
Clinton F. Stewart
机构：
[1] St. Jude Children’s Research Hospital,Department of Pharmaceutical Sciences
[2] St. Jude Children’s Research Hospital,Department of Biostatistics
[3] St. Jude Children’s Research Hospital,Division of Neuro
来源：
Cancer Chemotherapy and Pharmacology | 2019年 / 84卷
关键词：
Erlotinib; Pharmacokinetics; Pediatrics; Toxicity; Brain tumors;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：829 / 838
页数：9
相关论文
共 27 条
  • [1] Pharmacokinetics and safety of erlotinib and its metabolite OSI-420 in infants and children with primary brain tumors
    Reddick, Samuel J.
    Campagne, Olivia
    Huang, Jie
    Onar-Thomas, Arzu
    Broniscer, Alberto
    Gajjar, Amar
    Stewart, Clinton F.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 84 (04) : 829 - 838
  • [2] Correction to: Pharmacokinetics and safety of erlotinib and its metabolite OSI-420 in infants and children with primary brain tumors
    Samuel J. Reddick
    Olivia Campagne
    Jie Huang
    Arzu Onar-Thomas
    Alberto Broniscer
    Amar Gajjar
    Clinton F. Stewart
    Cancer Chemotherapy and Pharmacology, 2020, 85 : 475 - 475
  • [3] Pharmacokinetics and safety of erlotinib and its metabolite OSI-420 in infants and children with primary brain tumors (vol 84, 829, 2019)
    Reddick, Samuel
    Campagne, Olivia
    Huang, Jie
    Onar-Thomas, Arzu
    Broniscer, Alberto
    Gajjar, Amar
    Stewart, Clinton F.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2020, 85 (02) : 475 - 475
  • [4] Effects of omeprazole and esomeprazole on the pharmacokinetics of erlotinib and its metabolite OSI-420 in rats
    Zheng, Xiaokang
    Li, Shuanglong
    Xue, Linlin
    Mo, Changhao
    Chen, Lijun
    Guo, Xue
    Zhao, Zerui
    Qiu, Xiangjun
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (04): : 6896 - 6901
  • [5] Plasma and cerebrospinal fluid pharmacokinetics of erlotinib and its active metabolite OSI-420
    Broniscer, Alberto
    Panetta, John C.
    O'Shaughnessy, Melinda
    Fraga, Charles
    Bai, Feng
    Krasin, Matthew J.
    Gajjar, Amar
    Stewart, Clinton F.
    CLINICAL CANCER RESEARCH, 2007, 13 (05) : 1511 - 1515
  • [6] The plasma and cerebrospinal fluid pharmacokinetics of erlotinib and its active metabolite (OSI-420) after intravenous administration of erlotinib in non-human primates
    Meany, Holly J.
    Fox, Elizabeth
    McCully, Cynthia
    Tucker, Chris
    Balis, Frank M.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 62 (03) : 387 - 392
  • [7] The plasma and cerebrospinal fluid pharmacokinetics of erlotinib and its active metabolite (OSI-420) after intravenous administration of erlotinib in non-human primates
    Holly J. Meany
    Elizabeth Fox
    Cynthia McCully
    Chris Tucker
    Frank M. Balis
    Cancer Chemotherapy and Pharmacology, 2008, 62 : 387 - 392
  • [8] Plasma and Pleural Fluid Pharmacokinetics of Erlotinib and its Active Metabolite OSI-420 in Patients With Non-Small-Cell Lung Cancer With Pleural Effusion
    Masago, Katsuhiro
    Togashi, Yosuke
    Fukudo, Masahide
    Terada, Tomohiro
    Irisa, Kaoru
    Sakamori, Yuichi
    Kim, Young Hak
    Mio, Tadashi
    Inui, Ken-ichi
    Mishima, Michiaki
    CLINICAL LUNG CANCER, 2011, 12 (05) : 307 - 312
  • [9] Pharmacokinetics of Erlotinib and Its Active Metabolite OSI-420 in Patients with Non-small Cell Lung Cancer and Chronic Renal Failure Who Are Undergoing Hemodialysis
    Togashi, Yosuke
    Masago, Katsuhiro
    Fukudo, Masahide
    Terada, Tomohiro
    Ikemi, Yasuaki
    Kim, Young Hak
    Fujita, Shiro
    Irisa, Kaoru
    Sakamori, Yuichi
    Mio, Tadashi
    Inui, Ken-ichi
    Mishima, Michiaki
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (05) : 601 - 605
  • [10] Simultaneous determination of OSI-774 and its major metabolite OSI-420 in human plasma by using HPLC with UV detection
    Zhang, WJ
    Siu, LL
    Moore, MJ
    Chen, EX
    JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2005, 814 (01): : 143 - 147
123